Emergent Biosolutions EBS Accounts Receivable, Allowance for Credit Loss
Accounts Receivable, Allowance for Credit Loss at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's accounts receivable, allowance for credit loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's accounts receivable, allowance for credit loss?
- Emergent Biosolutions (EBS) reported accounts receivable, allowance for credit loss of $800K in Q1 2026.
- How has Emergent Biosolutions's accounts receivable, allowance for credit loss changed year-over-year?
- Emergent Biosolutions's accounts receivable, allowance for credit loss decreased by 33.3% year-over-year, from $1.2M to $800K.
- What is the long-term trend for Emergent Biosolutions's accounts receivable, allowance for credit loss?
- Over 5 years (2020 to 2025), Emergent Biosolutions's accounts receivable, allowance for credit loss has grown at a -23.7% compound annual growth rate (CAGR), from $3.1M to $800K.